Tim Guilliams
完整简介
Tim Guilliams，Healx Ltd联合创始人兼CEO。曾是Cambridge Rare Disease Network (CamRARE)的创始董事和受托人，以及Cambridge Judge Business School的创业研究员。曾就读剑桥大学，获得生物物理学与神经科学博士学位。在此之前，他在布鲁塞尔自由大学获得了生物与化学工程的硕士学位。
动态时间线
- 2015论文Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation ↗Proceedings of the National Academy of Sciences
- 2013论文α-Synuclein Senses Lipid Packing Defects and Induces Lateral Expansion of Lipids Leading to Membrane Remodeling ↗Journal of Biological Chemistry
- 2010论文Structure and Properties of a Complex of α-Synuclein and a Single-Domain Camelid Antibody ↗Journal of Molecular Biology
汇总提到此人的 SVTR 信息流动态与创投评文章，以及本人的代表论文（逐篇核过署名单位）。